Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial

BACKGROUND: Afghanistan's national guidelines recommend chloroquine for the treatment of Plasmodium vivax infection, the parasite responsible for the majority of its malaria burden. Chloroquine resistance in P. vivax is emerging in Asia. Therapeutic responses across Afghanistan have not been ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Awab, Ghulam Rahim, Pukrittayakamee, Sasithon, Imwong, Mallika, Dondorp, Arjen M, Woodrow, Charles J, Lee, Sue Jean, Day, Nicholas PJ, Singhasivanon, Pratap, White, Nicholas J, Kaker, Faizullah
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864284/
https://www.ncbi.nlm.nih.gov/pubmed/20409302
http://dx.doi.org/10.1186/1475-2875-9-105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864284/
https://www.ncbi.nlm.nih.gov/pubmed/20409302
http://dx.doi.org/10.1186/1475-2875-9-105

Ejemplares similares